Egyptian Children's Cancer Hospital Foundation Selects Cerner Technology To Improve Care For Patients

Main Category: Cancer / Oncology
Also Included In: Pediatrics / Children's Health
Article Date: 27 Feb 2008 - 1:00 PST

email to a friend   printer friendly   view / write opinions   rate article

The Children's Cancer Hospital Foundation 57357 (CCHF) in Egypt announced that it has selected Cerner Corporation (NASDAQ:CERN) as the healthcare information technology (HIT) provider for Children's Cancer Hospital Egypt 57357. The hospital will use multiple Cerner Millennium® solutions to help clinicians provide state-of-the-art care for an estimated 1,500 pediatric cancer patients each year. This implementation is part of Cerner's growing worldwide business, which now includes clients on five continents and a global presence in more than 20 countries.

"Children's Cancer Hospital Egypt 57357 is focused on meeting the unique needs of each child and leveraging medical findings to help children in the whole community," said Dr. Sherif Abouelnaga, Children's Cancer Hospital Egypt 57357 Professor of pediatric oncology and VP of Academic Affairs, Research and Outreach. "We have partnered with Cerner to implement technology that will help us ensure safety and reliability in the delicate process of caring for pediatric cancer patients."

CCHF was founded with a mission to care for pediatric cancer patients free of charge regardless of race, creed or financial status. The Foundation, which is funded by donations from the people of Egypt and philanthropists from around the globe, began building the region's first pediatric oncology hospital in one of Cairo's oldest suburbs in 2001. The hospital opened select areas in July 2007, treating more than 500 patients in its first four months of operation. A full grand opening is scheduled for the end of 2008/early 2009.

When complete, Children's Cancer Hospital Egypt 57357 will use a complementary suite of Cerner Millennium solutions to create a unified, patient-centric health record throughout the various hospital venues. Hospital administrators said they chose Cerner because they believe Cerner is best positioned to help them achieve their mission of delivering the highest-quality care possible to children. The solutions will be used to automate nursing communication, intensive care unit operations, clinician documentation, image management, pharmacy and laboratory operations, medication administration processes, patient accounting and surgery operations. Children's Cancer Hospital Egypt 57357 will also use Cerner Knowledge solutions to provide clinicians with access to knowledge-based, patient specific information.

"Our relationship with CCHF will help to link the findings from research and education by leveraging evidence-based care to transform clinical practice," said Amr Mostafa, Cerner Middle East Director. "Cerner has the solutions to help the CCHF create a hospital that utilizes leading-edge technology to provide clinicians with timely and easy access to information that is critical to patient care."

By selecting Cerner, Children's Cancer Hospital Egypt 57357 chose a supplier with a proven track record. Cerner has more than 7,500 Cerner Millennium solutions live at more than 1,200 client facilities around the world. Cerner technology helps healthcare organizations - ranging in size from independent physicians to nationwide healthcare organizations - streamline operations and improve the quality of care they deliver to patients.

As part of the Cerner Millennium implementation, the hospital also will implement ElDorado Donor™ software from Global Med Technologies®, Inc. (OTCBB:GLOB), an international e-Health, medical information technology company and parent of Wyndgate Technologies®. ElDorado Donor (510(k) pending, not for sale in the United States) is a comprehensive blood-management software application designed to manage, automate and control activities associated with donors, donor collections, testing, manufacturing, inventory and distribution of blood components in blood banks and donor centers.

About Children's Cancer Hospital Egypt 57357

Children's Cancer Hospital Egypt 57357 is a pediatric cancer hospital in the El Sayeda Zeinab district of Cairo, Egypt. The hospital currently houses 179 inpatient beds, a 300-patient outpatient facility, a specialized clinical pharmacy, intensive care and bone marrow transplant units, a comprehensive surgery department and multiple specialty clinics. Hospital 57357 is proud to be the home for several "firsts" in Egypt, including the first specialized department of psychology, social work and psychiatry for pediatric oncology patients; the first child life and school program for hospitalized children; and the first comprehensive physiotherapy department for oncology patients. To learn more about Children's Cancer Hospital Egypt 57357, visit http://www.57357.com.

About Cerner

Cerner is taking the paper chart out of healthcare, eliminating error, variance and waste in the care process. With more than 6,000 clients worldwide, Cerner is the leading supplier of healthcare information technology. The following are trademarks of Cerner: Cerner, Cerner's logo and Cerner Millennium. (NASDAQ:CERN).

This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "will" and "believe" or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; our proprietary technology may be subjected to infringement claims or may be infringed upon; risks associated with our global operations; recruitment and retention of key personnel; risks related to our reliance on third-party suppliers; changing political, economic and regulatory influences; government regulation; and, failure of the parties to achieve the intended benefits. Additional discussion of these and other factors affecting the Company's business is contained in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.

http://www.cerner.com